Nurix Therapeutics, Inc. NRIX
- NX-1607 — Microsatellite Stable Colorectal Cancer Phase 1
- NX-1607 — Non-Small Cell Lung Cancer Phase 1
- NX-1607 — Metastatic Castration-Resistant Prostate Cancer Phase 1
- NX-1607 — Melanoma Phase 1
CBL-B (1 companies · 4 programs)
Companies with an active program directed at CBL-B.